Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term cancer patients. Found 11 abstracts

Fleisher L, Wen KY, Miller SM, Diefenbach M, Stanton AL, Ropka M, Morra M, Raich PC. Development and utilization of complementary communication channels for treatment decision making and survivorship issues among cancer patients: The CIS Research Consortium Experience. Internet Interventions. 2015 Nov;2(4):392-8.   PMCID: 4740910
Matulonis UA, Sharma S, Ghamande S, Gordon MS, Del Prete SA, Ray-Coquard I, Kutarska E, Liu H, Fingert H, Zhou XF, Danaee H, Schilder RJ. Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma. Gynecologic Oncology. 2012 Oct;127(1):63-9.   PMCID: Not NIH Funded
Rodrigues G, Bae K, Roach M, Lawton C, Donnelly B, Grignon D, Hanks G, Porter A, Lepor H, Sandler H. IMPACT OF ULTRAHIGH BASELINE PSA LEVELS ON BIOCHEMICAL AND CLINICAL OUTCOMES IN TWO RADIATION THERAPY ONCOLOGY GROUP PROSTATE CLINICAL TRIALS. International Journal of Radiation Oncology Biology Physics. 2011 Jun;80(2):445-52.   PMCID: PMC2952349
Chism DB, Freedman GM, Li TY, Anderson PR. Re-excision of margins before breast radiation - Diagnostic or therapeutic?. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Aug;65(5):1416-21.
Meyer JS, Alvarez C, Milikowski C, Olson N, Russo I, Russo J, Glass A, Zehnbauer BA, Lister K, Parwaresch RG. Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index. Modern Pathology. 2005 Aug;18(8):1067-78.
Morrow M. Limiting breast surgery to the proper minimum. Breast. 2005 Dec;14(6):523-6.
Wu H, Barusevicius A, Babb J, Klein-Szanto A, Godwin A, Elenitsas R, Gelfand JM, Lessin S, Seykora JT. Pleiotrophin expression correlates with melanocytic tumor progression and metastatic potential. Journal of Cutaneous Pathology. 2005 Feb;32(2):125-30.
Hannoun-Levi JM, Mazeron JJ, Marsiglia H, Gerard JP. Partial breast irradiation: revolution or evolution?. Cancer Treatment Reviews. 2004 Nov;30(7):599-607.
Rogatko A, Babb JS, Wang H, Slifker MJ, Hudes GR. Patient characteristics compete with dose as predictors of acute treatment toxicity in early phase clinical trials. Clinical Cancer Research. 2004 Jul;10(14):4645-51.
Russo J, Russo IH. Genotoxicity of steroidal estrogens. Trends in Endocrinology and Metabolism. 2004 Jul;15(5):211-4.
Perez RP, Perez KM, Handel LM, Hamilton TC. Invitro Interactions between Platinum Analogs in Human Ovarian- Carcinoma Cell-Lines. Cancer Chemotherapy and Pharmacology. 1992 Apr;29(6):430-4.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term cancer patients

cancer patients radiation-therapy 20-year follow-up radiotherapy systemic therapy carcinoma conservative surgery breast cancer conserving therapy prognostic-factors whole-organ ng utilization Prognostic factors adult-rat cisplatin overexpression trial malignant-melanoma dysfunction quality-of-life cell preferences proliferation drugs breast conserving therapy carcinomas conserving surgery hormonal-therapy a kinase local recurrence microsatellite instability grade cost analysis intervention development ml resistance chemotherapy tissue positive margins Ovarian cancer Aurora A kinase-MLN8237-Platinum-refractory-Platinum-resistant thymidine labeling index Nuclear Medicine & Medical Imaging Radiology bromodeoxyuridine gene-expression Hormonal therapy high-dose carboplatin in-situ External beam radiation therapy cpt-11 surgical margin quality of life survival lumpectomy margin status diamminedichloroplatinum(ii) EHealth interventions multivariate-analysis combination tumors magnetic resonance imaging localization radical prostatectomy active breathing control Clinical trials breast epithelial-cells allelic imbalance flow-cytometry histological grade predict pathological stage local control s-phase fraction elderly-women interobserver agreement preoperative evaluation androgen suppression Prostate cancer breast neoplasms infiltrating ductal carcinoma phase-iii trial midkine protein experience messenger-rna cis- Outcomes heterozygosity postoperative radiotherapy i trials Oncology mitotic count competing risk comparing total mastectomy gleason score pegylated liposomal doxorubicin design Bloom-Richardson stage-i growth-factor pleiotrophin beta receptor-alpha partial breast irradiation pharmacokinetics er-alpha decision making surgical-management cell kinetics reproducibility randomized clinical-trial greater-than-20
Last updated on Wednesday, July 08, 2020